Linezolid Dextrose Injection GMP Manufacturer

• Application: Intravenous
• Usage Mode: Intravenous
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Intravenous
• Type: Biological Products
• Model NO.: 100ml
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H20213558
• Drug Ad Approval No.: None
• Certificate: GMP ISO
• Transport Package: by Sea/Air
• Specification: 60 bags/carton
• Trademark: Shimen
• Origin: China
• HS Code: 3004909099
• Production Capacity: 100000 Bags/Day

Product Description

 

Name	Common Name:Linezolid Dextrose Injection
Ingredient	The active pharmaceutical ingredient is Linezolid
Description	Colorless to light brown, clear liquid.
Indications	This product is used to treat the following infections caused by the specific microbial susceptible strains: Vancomycin-resistant Enterococcus faecium infections, Nosocomial pneumonia, Complicated skin and skin soft tissue infections, Uncomplicated skin and skin soft tissue infections , Community-acquired pneumonia and concomitant bacteremia.
Strength	100ml:0.2 g linezolid, 4.57 g anhydrous dextrose
Dosage and Administration	The recommended dosage administration of this product for treatment of infections is described in the instructions.